Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Sir Andrew Pollard reveals unique insights into the world of science in a new podcast

General

Oxford Vaccine Group and Pandemic Sciences Institute’s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.

Call for abstracts: International Pandemic Sciences Conference

General

Abstract submission for the International Pandemic Sciences Conference 2023 - Making the Exceptional Routine has been extended to Friday 28 April 2023.

£12 million investment for Future Vaccines Manufacturing Hub

General

A new Future Vaccines Manufacturing Hub – co-led by University of Oxford and University College London – aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.

Sarah Gilbert receives King Faisal Prize for Medicine

General

Professor Dame Sarah Gilbert has been awarded the prestigious King Faisal Prize in recognition of her work to co-create a COVID-19 vaccine that has saved an estimated six million lives.

New partnership to combat deadly pathogens

General

The Pandemic Sciences Institute and the UK's Defence Science and Technology Laboratory (Dstl) have agreed to jointly study the dangerous pathogens that could cause future pandemics.

NHS COVID-19 app saved estimated 10,000 lives in its first year, new research finds

General Research

A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.

PSI partners with Royal Veterinary College to bolster research into infectious disease

General

The Pandemic Sciences Institute announces a new partnership with the Royal Veterinary College to facilitate collaborative research into infectious diseases.

Why diversity matters in vaccine science

General

Professor Teresa Lambe sets out her advice for young scientists to mark the International Day of Women and Girls in Science.

Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award

General

A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.

Sarah Gilbert awarded 2023 King Faisal Prize

General

Professor Dame Sarah Gilbert, the Saïd Chair of Vaccinology in the Nuffield Department of Medicine has been selected to receive King Faisal Prize for Medicine for 2023, along with Professor Dan Barouch of Harvard Medical School.

Exclusive interview with Professor Miles Carroll

Here at VaccineNation we are delighted to kickstart the new year with another one of our recorded interviews from the World Vaccine Congress in Europe. As we look forward to the Congress in Washington in April, we will be releasing further interviews and exploring key themes for the event. For this interview we were lucky to secure a slot with Professor Miles Carroll of Oxford University. A specialist in high consequence emerging viral infections, his insight into how we respond to new threats and prepare for the future is incredibly exciting!

'Meet the man preparing Britain for the next pandemic'

Article from The Telegraph (14.12.22) about Professor Peter Horby and his plans for the PSI.

Research at the Outbreak of a Pandemic – thanking our donors

During the first lockdown in early 2020, an emergency Coronavirus Research Fund was set up to channel the huge amounts of gifts that started pouring in, and to direct them quickly to the research projects that had the biggest chance of mitigating the worst effects of the pandemic.

Oxford’s RECOVERY trial team amongst MRC‘s Outstanding Team Impact prize finalists

The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.

Oxford's Ebola vaccine recommended for deployment against Uganda outbreak

A vaccine developed by the Oxford Vaccine Group’s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from the Jenner Institute (Nuffield Department of Medicine) has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.

$3m Rockefeller Foundation funding to strengthen pandemic surveillance and response innovation co-developed by Oxford biologists

The Rockefeller Foundation has announced $3 million in new funding for Global.health (G.h) – a first-of-its-kind, open-source platform for scientific pandemic data. This will enable it to expand its international partnerships and modernize the global effort around coordinated pandemic prevention, surveillance, and response.

PSI hosts GOARN UK Partners Day

The Pandemic Sciences Institute is hosting the UK GOARN partners this week to discuss hot topics such as operational research and rapid response capacity during outbreaks.

Oxford contributes to new UK research consortium to tackle monkeypox

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium – in which the University of Oxford is a key partner – working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.

Oxford University launch new clinical trial to test a treatment for monkeypox

The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox. The National Institute for Health and Care Research (NIHR) has commissioned and funded the study. The first patients have now been recruited.

Oxford scientists honoured with eight Royal Society Awards

Each year, the Royal Society recognises exceptional research achievements through a series of prestigious medals and prizes named after great scientists of the past. Eight of the 2021-22 awards, announced today, honour Oxford University researchers for their outstanding contributions to science and medicine.

Load More